Navigation Links
WorldHeart Appoints David Pellone Chief Financial Officer
Date:8/31/2007

OAKLAND, Calif., Aug. 31 /PRNewswire-FirstCall/ -- World Heart Corporation (WorldHeart) (Nasdaq: WHRT, TSX: WHT), a developer of mechanical circulatory support systems, today announced the appointment of Mr. David Pellone as Vice President, Finance and Chief Financial Officer. Mr. Richard Juelis, the departing CFO, will provide consulting services through the end of the year to assist with the transition and with certain specific projects.

Mr. Pellone is an experienced financial executive with a track record of success with technology companies. He has extensive experience as Vice President of Finance and Chief Financial Officer with a number of companies. His prior work experience includes Condor Power Supplies Incorporated, Flash Electronics Incorporated, RAE Systems Incorporated, AG Associates, Incorporated and the Medical Products and Services Division of 3M Corporation. He has also consulted with several companies, including WorldHeart, in areas ranging from public reporting to internal controls compliance.

"We are delighted to have David Pellone join WorldHeart as CFO. He brings a wealth of financial expertise to WorldHeart including experience with public technology companies," said Jal S. Jassawalla, WorldHeart's President and Chief Executive Officer. "I would like to thank Rich Juelis, personally and on behalf of WorldHeart, for his many contributions in completing and integrating the acquisition of MedQuest, the developer of our Levacor(TM) VAD, and the streamlining of operations and finance functions. We also look forward to his transitional assistance to WorldHeart."

About WorldHeart

World Heart Corporation is a developer of mechanical circulatory support systems with leading next-generation technologies, headquartered in Oakland, California, with additional facilities in Salt Lake City, Utah and in the Netherlands. WorldHeart's registered office is Ottawa, Ontario, Canada.


'/>"/>
SOURCE World Heart Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The Emotional Side of David Beckham Revealed
2. UNAIDS Chief Appeals for Projects to Battle AIDS/HIV
3. EU medical chief says Europe ready for bird flu
4. Reminiscences of Chief Justice’s Call for Quality Medical Educatio
5. Joining The Military My Best Move - US Army Nursing Chief
6. Making Budhia run 65 km absolutely cruel,says Infosys chief
7. WHO Chiefs Sudden Death - A Major Loss To Global Health
8. FDA chief takes decision without two senior officials’ opinion
9. Interim WHO Chief Confirms No radical changes in WHO
10. Chiefs Of Regional Commissions For Animal Health Announced
11. A&E departments To Be Shut Down warns NHS chief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... ... Today, the Centers for Medicare & Medicaid Services (CMS) announced over 359,000 clinicians ... Clinicians who participate in APMs are paid for the quality of care they give ... build a system that delivers better care and one in which clinicians work together ...
(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy Network announced the ... 503A compounding pharmacy located in Ocala, Florida. , Meeting the Needs of ... the United States for high-quality human anti-aging and wellness compounded medications, ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots , ... from around the world, announces the launch of its newly redesigned website. The ... to research breakthroughs and trending news, vital information on upcoming virtual events and ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online ... procedures in order to make it easier for their readers to get the information ... they impact as well as the techniques used on those particular areas. , “We ...
(Date:1/19/2017)... NJ (PRWEB) , ... January 19, 2017 , ... ... certified dermatologist by the American Board of Dermatology and fellowship trained Mohs and ... the National Institutes of Health, Dr. Li completed his internship in internal medicine ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Shire plc (LSE: SHP, NASDAQ: ... Drug Administration (FDA) has acknowledged receipt of the Class ... SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. SHP465 ... Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to provide ... designated Prescription Drug User Fee Act (PDUFA) action date. ...
(Date:1/19/2017)... 19, 2017 The global  pacemaker market  is expected to ... View Research, Inc. The heightening prevalence of cardiac conditions coupled with the availability ... globally. In addition, technological enhancements in these devices are supporting the expansion of ... ... Grand View Research Logo ...
(Date:1/19/2017)... Md. , Jan. 18, 2017   ... late-stage clinical company developing therapeutics designed to preserve ... of patients, today confirmed plans to initiate a ... Company,s modified-release reformulation of lovastatin lactone designed to ... smithii) in the gut to treat the ...
Breaking Medicine Technology: